TuHURA Biosciences (HURA) Shares Outstanding (2010 - 2026)
TuHURA Biosciences' (HURA) quarterly Shares Outstanding (Entity) came in at $9774.0 in Q3 2020, up 126.88% year-on-year from $4308.0 in Q4 2019, and up 49.7% quarter-over-quarter from $6529.0 in Q1 2020.
TuHURA Biosciences (HURA) Shares Outstanding (2010 - 2026) Analysis & Trends
TuHURA Biosciences' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $9774.0 for Q3 2020.
- On a quarterly basis, Shares Outstanding (Entity) rose 126.88% year-over-year to $9774.0 in Q3 2020; TTM through Sep 2020 was $9774.0, a 126.88% increase from a year earlier, with the FY2016 full-year figure at $639.0, up 13.3% from the prior year.
- Shares Outstanding (Entity) rose to $9774.0 in Q3 2020 per HURA's latest filing, from $6529.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $9774.0 in Q3 2020 and bottomed at $633.0 in Q1 2016.
- The 5-year median for Shares Outstanding (Entity) is $1309.0 (2018), against an average of $2544.0.
- Across the five-year window, Shares Outstanding (Entity) rose 3.63% in 2016 and soared 336.55% in 2019, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $656.0 in 2016, then jumped by 96.95% to $1292.0 in 2017, then rose by 15.63% to $1494.0 in 2018, then surged by 336.55% to $6522.0 in 2019, then jumped by 49.86% to $9774.0 in 2020.
- Per Business Quant, the three latest HURA Shares Outstanding (Entity) figures stand at $9774.0 (Q3 2020), $6529.0 (Q1 2020), and $6522.0 (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 198.10 Mn |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | 60.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.01 Mn |
| Dec 31, 2025 | 47.93 Mn |
| Sep 30, 2025 | 50.67 Mn |
| Jun 30, 2025 | 44.56 Mn |
| Mar 31, 2025 | 43.40 Mn |
| Dec 31, 2024 | 18.66 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 752,877.00 |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 123,908.00 |
| Sep 30, 2023 | 49,083.00 |
| Jun 30, 2023 | 46,283.00 |
| Mar 31, 2023 | 48,026.00 |
| Dec 31, 2022 | 46,941.00 |
| Sep 30, 2022 | 41,829.00 |
| Jun 30, 2022 | 27,828.00 |
| Mar 31, 2022 | 28,072.00 |
| Dec 31, 2021 | 27,729.00 |
| Sep 30, 2021 | 19,588.00 |
| Jun 30, 2021 | 14,791.00 |